BNP Paribas Arbitrage SA boosted its holdings in Orthofix International N.V. (NASDAQ:OFIX) by 64.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,651 shares of the medical device company’s stock after acquiring an additional 2,995 shares during the period. BNP Paribas Arbitrage SA’s holdings in Orthofix International N.V. were worth $356,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Orthofix International N.V. by 18.6% in the 1st quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock valued at $69,278,000 after acquiring an additional 284,482 shares during the period. Dimensional Fund Advisors LP raised its stake in Orthofix International N.V. by 2.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 779,771 shares of the medical device company’s stock valued at $29,748,000 after acquiring an additional 20,473 shares during the period. Wellington Management Group LLP bought a new stake in Orthofix International N.V. in the 1st quarter valued at $20,021,000. Oakview Capital Management L.P. raised its stake in Orthofix International N.V. by 2.9% in the 1st quarter. Oakview Capital Management L.P. now owns 510,699 shares of the medical device company’s stock valued at $19,483,000 after acquiring an additional 14,491 shares during the period. Finally, State Street Corp raised its stake in Orthofix International N.V. by 27.0% in the 1st quarter. State Street Corp now owns 462,479 shares of the medical device company’s stock valued at $17,640,000 after acquiring an additional 98,212 shares during the period. Institutional investors and hedge funds own 94.40% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Orthofix International N.V. (OFIX) Shares Bought by BNP Paribas Arbitrage SA” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/09/18/orthofix-international-n-v-ofix-shares-bought-by-bnp-paribas-arbitrage-sa.html.

Orthofix International N.V. (NASDAQ OFIX) opened at 48.67 on Monday. The firm has a 50-day moving average price of $47.51 and a 200-day moving average price of $42.89. The firm has a market capitalization of $884.33 million, a price-to-earnings ratio of 113.98 and a beta of 0.22. Orthofix International N.V. has a one year low of $32.51 and a one year high of $50.40.

Orthofix International N.V. (NASDAQ:OFIX) last issued its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.01. The firm had revenue of $108.90 million for the quarter, compared to analyst estimates of $102.94 million. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.41 earnings per share. Analysts expect that Orthofix International N.V. will post $1.56 EPS for the current year.

In other Orthofix International N.V. news, CEO Brad Mason sold 2,733 shares of the business’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $48.10, for a total value of $131,457.30. Following the sale, the chief executive officer now directly owns 188,053 shares in the company, valued at $9,045,349.30. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Raymond Fujikawa sold 6,364 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $47.06, for a total value of $299,489.84. Following the completion of the sale, the insider now owns 31,084 shares in the company, valued at $1,462,813.04. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 23,406 shares of company stock worth $1,138,531. Corporate insiders own 5.60% of the company’s stock.

A number of research firms recently weighed in on OFIX. BidaskClub upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $55.00 price objective (up from $50.00) on shares of Orthofix International N.V. in a report on Thursday, August 10th. TheStreet raised Orthofix International N.V. from a “c+” rating to a “b-” rating in a report on Tuesday, August 8th. Zacks Investment Research raised Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price objective on the stock in a report on Thursday, August 10th. Finally, BTIG Research initiated coverage on Orthofix International N.V. in a report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price objective on the stock. Seven equities research analysts have rated the stock with a buy rating, Orthofix International N.V. currently has an average rating of “Buy” and an average price target of $52.75.

Orthofix International N.V. Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Stock Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related stocks with our FREE daily email newsletter.